Clover Health is trading at $4.38 (-4.27%) after no clear company-specific catalyst emerged on August 11, 2026.
- Management participated in the scheduled Canaccord Genuity Growth Conference at 8:30 a.m. ET; available coverage has not linked it to the decline.
- Broader markets were nearly flat as investors awaited CPI amid elevated oil and rate concerns.